Finance

Lists
Why is CARL down 4.31%?
Dive Deeper
CARL:NASDAQ
Carlsmed Inc
$14.64
-4.31%
(-0.66) 1D
$14.64
0.00% (0.00)
After hours
Closed: Oct 6, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CARL...
Open
$15.43
High
$15.43
Low
$14.56
Mkt. cap
372.80M
Avg. vol.
93.67K
Volume
115.65K
52-wk high
$17.23
52-wk low
$8.50
EPS
-$1.44
Shares outstanding
27.30M
No. of employees
127
Open
$15.43
High
$15.43
Low
$14.56
Mkt. cap
372.80M
Avg. vol.
93.67K
Volume
115.65K
52-wk high
$17.23
52-wk low
$8.50
EPS
-$1.44
Shares outstanding
27.30M
No. of employees
127
News stories
From web sources and news partners
About Carlsmed Inc
CEO-
Employees127
Founded2018
HeadquartersCarlsbad, California, United States
SectorMedical device
Websitecarlsmed.com
Analyst ratings
Based on 5 analysts giving stock ratings to CARL in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for CARL in the last 3 months.
Highest
Current $14.64
$23.00 (+57.10%)
Average
$19.33 (+32.04%)
Lowest
$17.00 (+16.12%)
Analyst
Recommendation
Action
Price target
Projected
Date
Richard Newitter
Truist Financial
Buy
Reiterated
-
-
09/29/2026
Ryan Zimmerman
BTIG
Buy
Maintained
$23.00
+57.1%
09/28/2026
Travis Steed
Bank of America Securities
Buy
Maintained
-
-
08/13/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$18.00
+23%
08/06/2026
David Saxon
Needham
Buy
Reiterated
$17.00
+16.1%
08/06/2026
David Roman
Goldman Sachs
Buy
Maintained
$16.00
+9.3%
05/05/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.39 / -$0.47
+17.02%beat
Revenue / Est. (USD)
18.94M / 17.80M
+6.40%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.07M
15.16M
16.12M
18.94M
Cost of goods sold
3.15M
3.56M
3.69M
4.40M
Cost of revenue
3.15M
3.56M
3.69M
4.40M
Research and development expenses
4.44M
5.26M
5.18M
6.04M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.52M
15.66M
16.52M
19.54M
Operating expense
18.96M
20.93M
21.70M
25.58M
Total operating expenses
22.11M
24.48M
25.39M
29.98M
Operating income
-9.04M
-9.32M
-9.28M
-11.04M
Other non operating income
-65.00K
7.00K
-
-
EBT including unusual items
-8.53M
-8.61M
-8.70M
-10.51M
EBT excluding unusual items
-8.53M
-8.61M
-8.70M
-10.51M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.53M
-8.61M
-8.70M
-10.51M
Net profit margin
-65.21%
-56.80%
-53.96%
-55.49%
Earnings per share
-0.37
-0.29
-0.26
-0.39
Interest and investment income
954.00K
1.03M
891.00K
839.00K
Interest expense
-380.00K
-330.00K
-311.00K
-313.00K
Net interest expenses
574.00K
698.00K
580.00K
526.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.95M
-9.22M
-9.18M
-10.91M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps